SKYE Skye Bioscience, Inc. logo

SKYE Skye Bioscience, Inc.

Healthcare
$0.82-0.87%ClosedMarket Cap: $28.9M

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

35

Dispositions

17

Buy/Sell Ratio

2.06

Net Shares

+1,390,211

Shares Acquired

3,316,358

Shares Disposed

1,926,147

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Apr 28Sharp John PofficerSell0$0.000
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell200,000$5.150
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell75,000$14.560
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell12,000$4.250
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell200,000$0.62200,000
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell150,000$0.62150,000
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell75,000$0.6175,000
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell17,004$0.6217,004
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell12,000$0.6212,000
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell7,100$0.627,100
Thu Apr 02Smith Karen L.directorSell75,000$0.6275,000
Mon Feb 09Twitty Christopherofficer: Chief Scientific OfficerSell150,000$0.82150,000
Mon Feb 09Smith Karen L.directorSell35,000$0.8235,000
Mon Feb 09Schwab Andrew J.directorSell35,000$0.8235,000
Mon Feb 09Jenkins AnnalisadirectorSell35,000$0.8235,000